No pressure tactics were observed across our testing
This is because Ozempic is designed to treat type 2 diabetes and Wegovy is designed for weight loss
A meta-analysis published in Diabetes, Obesity and Metabolism found no significant increase in fracture risk associated with GLP-1 therapy

monthly cost Best use case BPC-157 Tissue repair, gut healing, angiogenesis Moderate (strong animal, limited human) Restricted (FDA compounding crackdown) $50 to $150 Gut health, injury and tissue repair Epitalon Telomerase activation, pineal support Low to moderate (animal, small human) Gray market / research use $60 to $200 Cellular aging, sleep regulation Thymosin Alpha-1 Immune modulation, T-cell function Strong (approved in 35+ countries) Available by prescription $100 to $300 Immune aging, infection support GHK-Cu Collagen synthesis, antioxidant, gene expression Moderate (human skin, animal systemic) Topical OTC, injectable by Rx $30 to $100 Skin aging, wound healing FOXO4-DRI Senolytic, clears senescent cells Early (animal data only) Research use only $200 to $500+ Cellular senescence Humanin Mitochondrial and neuroprotection Early to moderate (human observational, animal) Research use only Varies Mitochondrial aging, neurodegeneration SS-31 (Elamipretide) Mitochondrial membrane repair Moderate (clinical trials ongoing) Clinical trial / compassionate use Not commercially available Mitochondrial and cardiac aging CJC-1295 / Ipamorelin Growth hormone secretion Moderate (human PK data, clinical use) Restricted (FDA compounding crackdown) $100 to $250 Body composition, recovery, sleep The honest picture It is all about the evidence spectrum
